D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$700M |
| 2 |
Qualcomm
QCOM
|
+$525M |
| 3 |
Marathon Petroleum
MPC
|
+$522M |
| 4 |
Walmart Inc
WMT
|
+$503M |
| 5 |
Ford
F
|
+$474M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$672M |
| 2 |
Merck
MRK
|
+$476M |
| 3 |
Meta Platforms (Facebook)
META
|
+$392M |
| 4 |
McDonald's
MCD
|
+$372M |
| 5 |
Wells Fargo
WFC
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.62% |
| 2 | Consumer Discretionary | 9.84% |
| 3 | Healthcare | 7.45% |
| 4 | Communication Services | 7.19% |
| 5 | Financials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
T. Rowe Price
TROW
$25B
| $10.6M | 0.01% |
53,306
-49,298
| -48% | -$9.22M |
|
1327
General Motors
GM
$74.7B
| $10.5M | 0.01% |
178,190
-240,658
| -57% | -$14.1M |
|
|
CVIIU
1328
DELISTED
Churchill Capital Corp VII Units
CVIIU
| $10.5M | 0.01% |
1,053,009
+849,370
| +417% | +$8.52M |
|
|
ETRN
1329
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $10.5M | 0.01% |
1,237,902
+221,757
| +22% | +$1.88M |
|
1330
PUT
Halliburton
HAL
$27.9B
| $10.5M | 0.01% |
455,000
-180,000
| -28% | -$4M |
|
1331
CALL
Albemarle
ALB
$13.5B
| $10.5M | 0.01% |
62,100
+18,300
| +42% | +$2.95M |
|
1332
Cirrus Logic
CRUS
$6.74B
| $10.4M | 0.01% |
122,565
+41,825
| +52% | +$3.35M |
|
1333
PUT
Union Pacific
UNP
$183B
| $10.4M | 0.01% |
+47,400
| New | +$10.6M |
|
1334
CALL
Capital One
COF
$124B
| $10.4M | 0.01% |
67,100
-100,200
| -60% | -$15.1M |
|
|
SWTX
1335
DELISTED
SpringWorks Therapeutics
SWTX
| $10.4M | 0.01% |
125,879
-24,362
| -16% | -$1.85M |
|
1336
PUT
Macy's
M
$6.15B
| $10.4M | 0.01% |
546,800
-7,500
| -1% | -$133K |
|
1337
Vir Biotechnology
VIR
$1.47B
| $10.4M | 0.01% |
219,228
+102,936
| +89% | +$4.68M |
|
1338
Toro Company
TTC
$8.93B
| $10.4M | 0.01% |
94,308
-30,076
| -24% | -$3.31M |
|
1339
PUT
CRISPR Therapeutics
CRSP
$4.58B
| $10.4M | 0.01% |
64,000
-61,500
| -49% | -$7.48M |
|
1340
Opko Health
OPK
$921M
| $10.4M | 0.01% |
2,556,582
-979,049
| -28% | -$3.84M |
|
1341
Leggett & Platt
LEG
$1.52B
| $10.3M | 0.01% |
199,458
+94,385
| +90% | +$4.91M |
|
1342
American Express
AXP
$223B
| $10.3M | 0.01% |
62,536
-580,157
| -90% | -$90.9M |
|
1343
Arcturus Therapeutics
ARCT
$157M
| $10.3M | 0.01% |
305,090
+225,152
| +282% | +$7.62M |
|
1344
United Airlines
UAL
$38.4B
| $10.3M | 0.01% |
196,827
-166,037
| -46% | -$9.21M |
|
1345
Bilibili
BILI
$7.18B
| $10.3M | 0.01% |
84,462
-948,847
| -92% | -$103M |
|
1346
Sabra Healthcare REIT
SBRA
$5.64B
| $10.3M | 0.01% |
565,303
+27,815
| +5% | +$495K |
|
1347
BridgeBio Pharma
BBIO
$16.5B
| $10.3M | 0.01% |
168,734
+142,975
| +555% | +$8.17M |
|
1348
CALL
Deere & Co
DE
$170B
| $10.3M | 0.01% |
29,100
+19,600
| +206% | +$7.15M |
|
1349
BP
BP
$113B
| $10.3M | 0.01% |
388,464
-89,733
| -19% | -$2.35M |
|
1350
Regenxbio
RGNX
$623M
| $10.2M | 0.01% |
261,770
+5,545
| +2% | +$198K |
|
Similar funds
D.E. Shaw & Co's Q2 2021 Portfolio in Review
As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
- D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
- D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
- D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
- D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.